ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,939Medicare Part D Prescriptions Filled, Including Refills

Rank: 150 out of 761

$362K Total Retail Price of All Prescriptions

Rank: 247 out of 761

430 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
7% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 430 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

17% of this provider’s 430 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 8,505 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
ATORVASTATIN CALCIUM 349 339 1 12
LEVOTHYROXINE SODIUM 307 293 2 3
SIMVASTATIN 298 283 3 2
HYDROCODONE-ACETAMINOPHEN 295 279 S3 4 5
LISINOPRIL 264 247 5 1
OMEPRAZOLE 262 245 6 4
PRAVASTATIN SODIUM 238 235 7 20
AMLODIPINE BESYLATE 235 219 8 6
POTASSIUM CHLORIDE 234 222 9 18
METFORMIN HCL 176 153 10 10
ALENDRONATE SODIUM 167 162 11 21
LOSARTAN POTASSIUM 155 139 12 13
WARFARIN SODIUM 153 153 13 9
CHLORTHALIDONE 148 148 14 89
SYNTHROID 137 137 15 64
FUROSEMIDE 132 132 16 7
METOPROLOL SUCCINATE 130 117 17 16
HYDROCHLOROTHIAZIDE 125 125 18 11
ATENOLOL 117 112 19 8
SPIRONOLACTONE 112 100 20 45
GABAPENTIN 107 103 21 15
GLIMEPIRIDE 105 96 22 48
ALLOPURINOL 104 104 23 28
LOVASTATIN 104 81 23 17
METOPROLOL TARTRATE 102 101 25 14
TAMSULOSIN HCL 102 102 25 27
SPIRONOLACTONE-HCTZ 101 84 27 177
DIGOXIN 88 88 28 43
ZOLPIDEM TARTRATE 79 79 29 22
ENALAPRIL MALEATE 75 75 30 71
FLUOXETINE HCL 75 63 30 31
AMOXICILLIN 68 66 32 200
PANTOPRAZOLE SODIUM 66 53 33 40
TRAZODONE HCL 64 62 34 23
TRIAMTERENE-HCTZ 62 62 35 42
CLOPIDOGREL 62 62 35 66
RANITIDINE HCL 57 49 37 52
DONEPEZIL HCL 53 53 38 33
CAPTOPRIL 51 42 39 341
LANTUS 50 49 40 41
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.